PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study

被引：0

作者：

Zhang, Hanwen ^{[1
]}

Wang, Shuhua ^{[1
]}

Rupji, Manali ^{[2
]}

Wu, Chenxi ^{[3
]}

Chandrasekaran, Sanjay ^{[4
]}

Funk, Christopher R. ^{[1
]}

King, Patrick J. ^{[5
]}

Kollipara, Saketh ^{[6
]}

Rao, Ishani ^{[6
]}

Ayanru, Esohe ^{[6
]}

Duffy, Julia ^{[7
]}

Kaplow, Roberta ^{[7
]}

Abousaud, Aseala ^{[8
]}

Mehta, Aneesh ^{[9
]}

Roback, John D. ^{[5
]}

Kalman, Daniel ^{[5
]}

Lyon, G. Marshall, III ^{[9
]}

Caridi-Scheible, Mark ^{[10
]}

Bisson, Gregory ^{[11
]}

Liu, Yuan ^{[2
]}

Coma, Silvia ^{[12
]}

Pachter, Jonathan A. ^{[12
]}

Giver, Cynthia R. ^{[1
]}

Waller, Edmund K. ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[2] Emory Univ, Winship Canc Inst, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA

[3] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA

[4] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA

[5] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA

[6] Emory Univ, Atlanta, GA 30322 USA

[7] Emory Univ Hosp, Emory Healthcare, 1364 Clifton Rd NE, Atlanta, GA 30322 USA

[8] Emory Healthcare, Atlanta, GA USA

[9] Emory Univ, Sch Med, Dept Infect Dis, Atlanta, GA 30322 USA

[10] Emory Univ, Sch Med, Crit Care Med, Atlanta, GA 30322 USA

[11] Univ Penn, Perelman Sch Med, Div Infect Dis, Dept Med, Philadelphia, PA 19104 USA

[12] Verastem Oncol, Needham, MA USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-165567

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：11187 / 11189

页数：3

共 50 条

[1] Phase 3 Placebo-Controlled, Randomized Clinical Trial Outcomes of PI3K Delta Inhibitor Leniolisib in Patients with Activated PI3K Delta Syndrome (APDS/PASLI)
Rao, V. Koneti
Webster, Sharon
Sediva, Anna
Plebani, Alessandro
Schuetz, Catharina
Shcherbina, Anna
Conlon, Niall
Coulter, Tanya
Dalm, Virgil
Trizzino, Antonino
Zharankova, Yulia
Kulm, Elaine
Koerholz, Julia
Lougaris, Vassilios
Rodina, Yulia
Kucher, Klaus
Radford, Kath
Bradt, Jason
Uzel, Gulbu
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S4 - S5
[2] Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
Piemonti, Lorenzo
Landoni, Giovanni
Voza, Antonio
Puoti, Massimo
Gentile, Ivan
Coppola, Nicola
Nava, Stefano
Mattei, Alessia
Marinangeli, Franco
Marchetti, Giulia
Bonfanti, Paolo
Mastroianni, Claudio Maria
Bassetti, Matteo
Crisafulli, Ernesto
Grossi, Paolo Antonio
Zangrillo, Alberto
Desai, Antonio
Merli, Marco
Foggia, Maria
Carpano, Marco
Schiavoni, Lorenzo
Monforte, Antonella D'Arminio
Bisi, Luca
Russo, Gianluca
Busti, Fabiana
Rovelli, Cristina
Perrotta, Elisabetta
Goisis, Giovanni
Gavioli, Elizabeth M.
Toya, Sophie
De Pizzol, Maria
Mantelli, Flavio
Allegretti, Marcello
Minnella, Enrico Maria
INFECTIOUS DISEASES AND THERAPY, 2023, 12 (10) : 2437 - 2456
[3] Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
Lorenzo Piemonti
Giovanni Landoni
Antonio Voza
Massimo Puoti
Ivan Gentile
Nicola Coppola
Stefano Nava
Alessia Mattei
Franco Marinangeli
Giulia Marchetti
Paolo Bonfanti
Claudio Maria Mastroianni
Matteo Bassetti
Ernesto Crisafulli
Paolo Antonio Grossi
Alberto Zangrillo
Antonio Desai
Marco Merli
Maria Foggia
Marco Carpano
Lorenzo Schiavoni
Antonella D’Arminio Monforte
Luca Bisi
Gianluca Russo
Fabiana Busti
Cristina Rovelli
Elisabetta Perrotta
Giovanni Goisis
Elizabeth M. Gavioli
Sophie Toya
Maria De Pizzol
Flavio Mantelli
Marcello Allegretti
Enrico Maria Minnella
Infectious Diseases and Therapy, 2023, 12 : 2437 - 2456
[4] Cova Results From a Double-blind, Placebo-controlled Phase 2/3 Study to Assess Efficacy and Safety of BIO101 in Hospitalized Severe COVID-19 Patients
Nair, G. B.
Dioh, W.
Chabane, M.
Tourette, C.
Rabut, S.
Louze, M.
Esmeraldino, L.
Camelo, S.
Mariani, J.
Latil, M.
Lafont, R.
Dilda, P.
Agus, S.
Maanen, R.
Veillet, S.
Morelotpanzini, C.
Plantefeve, G.
Lobo, S. M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[5] A randomized, placebo-controlled phase 3 trial of the PI3K8 inhibitor leniolisib for activated PI3K8 syndrome
Rao, V. Koneti
Webster, Sharon
Sediva, Anna
Plebani, Alessandro
Schuetz, Catharina
Shcherbina, Anna
Conlon, Niall
Coulter, Tanya
Dalm, Virgil A.
Trizzino, Antonino
Zharankova, Yulia
Kulm, Elaine
Koerholz, Julia
Lougaris, Vassilios
Rodina, Yulia
Radford, Kath
Bradt, Jason
Kucher, Klaus
Relan, Anurag
Holland, Steven M.
Lenardo, Michael J.
Uzel, Gulbu
BLOOD, 2023, 141 (09) : 971 - 983
[6] Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial
Kim, Myung-Ho
Elbaz, Josh
Jilg, Nikolaus
Gustafson, Jenna L.
Xu, Min
Hatipoglu, Dilara
Nohelty, Eric
Kim, Arthur Y.
Chung, Raymond T. T.
FRONTIERS IN MEDICINE, 2023, 10
[7] Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19
Joseph A. Lasky
Jyotsna Fuloria
Marion E. Morrison
Randall Lanier
Odin Naderer
Tom Brundage
Allen Melemed
Advances in Therapy, 2021, 38 : 782 - 791
[8] Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19
Lasky, Joseph A.
Fuloria, Jyotsna
Morrison, Marion E.
Lanier, Randall
Naderer, Odin
Brundage, Tom
Melemed, Allen
ADVANCES IN THERAPY, 2021, 38 (01) : 782 - 791
[9] Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
Yeming Wang
Fei Zhou
Dingyu Zhang
Jianping Zhao
Ronghui Du
Yi Hu
Zhenshun Cheng
Ling Gao
Yang Jin
Guangwei Luo
Shouzhi Fu
Qiaofa Lu
Guanhua Du
Ke Wang
Yang Lu
Guohui Fan
Yi Zhang
Ying Liu
Shunan Ruan
Wen Liu
Thomas Jaki
Frederick G. Hayden
Peter W. Horby
Bin Cao
Chen Wang
Trials, 21
[10] Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)
Ison, Michael G.
Weinstein, Debra F.
Dobryanska, Marta
Holmes, Anna
Phelan, Anne-Marie
Li, Yong
Gupta, Deepali
Narayan, Kristin
Tosh, Kazima
Hershberger, Ellie
Connolly, Lynn E.
Yalcin, Ilker
Campanaro, Ed
Hawn, Pamela
Schmidt, Pete
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (07):

← 1 2 3 4 5 →